VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 2nd ASIA PACIFIC ECHOCARDIOGRAPHY COURSE Post Luc M.

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 09, 2024 8:03am

91 Views

Post# 36124050

2nd ASIA PACIFIC ECHOCARDIOGRAPHY COURSE Post Luc M.

Bandung, July 5^th-7^th, 2024

2^nd ASIA PACIFIC ECHOCARDIOGRAPHY COURSE on Congenital Heart Disease: Basic to Advanced Imaging

Posts by Luc

View Luc Mertens’ profile
• 3rd+

Head Echocardiography

Reposted from Andrew Cook • 2h •

What an amazing educational event! Wonderful organization, great faculty, and very engaged and dedicated audience. Thank you Budi and team♥!! Looking forward to the next edition in the Asian Pacific region.